Government watchdog calls for oversight of for-profit IRBs; Pfizer scraps half of participants in Lyme drug trial

Taking stock of the drug industry, from the lab to the medicine chest

February 24, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

ROBYN BECK/AFP via Getty Images A dozen states sue the FDA in hopes of easing abortion pill restrictions A dozen states filed a lawsuit to force the FDA to ease restrictions on how mifepristone is prescribed and made available to patients. By Ed Silverman STAT+ | Little transparency, lots of waste: NIH funds pediatric research, but many trials results go unpublished The authors of the analysis estimated that the likelihood results would be published was just 54% four years after NIH grants were completed. By Ed Silverman Amid fentanyl crisis, first-of-its-kind study to evaluate expanded methadone access A new trial will attempt to compare patients' ability to remain in treatment when prescribed buprenorphine or methadone in an office setting. By Lev Facher AP Photo/Gene J. Puskar Medicare for all … of East Palestine? Could an Obamacare policy help ensure Medicare coverage for the thousands of Ohioans who might get sick after the major train derailment? By Sarah Owermohle VP Harris: Abortion pill case could take 'constitutional right' from Americans A looming Texas court decision on abortion pills could impact nationwide access to medication, Vice President Kamala Harris warned. By Sarah Owermohle Opinion: Fixing U.S. public health will require a health-systems revolution — and for physicians to take a backseat A classic warning in public health goes like this: "A society that spends so much on health care that it cannot or will not spend adequately on other health enhancing activities may actually be reducing the health of its population." No nation is as guilty of this practice as the United States, with its extremely high health expenditures alongside abysmal population-level health outcomes. But the medical field's corrosion of public health doesn't stop at budgets and policies. Through its stranglehold on resources and institutional power, the U.S. medical profession has also come to distort the very definition of public health and what is now widely believed to constitute relevant knowledge. By Eric Reinhart

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser